Acute Myelogenous Leukemia or Myelodysplastic Syndrome

People with acute myelogenous leukemia are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have adequate organ function
  • Have the ability to swallow or retain oral medications

You may NOT participate in this study if you:

  • Have received major surgery or chemotherapy treatment in past 14 days
  • Have been diagnosed with acute promyelocytic or CNS leukemia
  • Have known cardiovascular disease or gastrointestinal disease
  • Have fungal, viral, or bacterial infection
  • Have known immunodeficiency virus (HIV) infection, Hepatitis B, or Hepatitis C
  • Are pregnant or breastfeeding

Contact Information
Prafulla Bhagat, Study Coordinator
1695 Eastchester Road Room 225
Bronx, New York 10467
Phone: (718) 405-8545

Email: prafulla.bhagat@einsteinmed.org

 

Patients Relapsed Refractory Leukemias

People with relapsed/refractory leukemias are asked to participate in a research study being conducted by Montefiore Medical Center

You may be eligible to participate in this study if you:

  • Are a male or female 18 years of age or older

You may NOT participate in this study if you:

  • Have known human immunodeficiency virus (HIV), Hepatitis B and Hepatitis C
  • Are pregnant, breastfeeding or plan to become pregnant

Contact Information
Prafulla Bhagat, Regulatory Coordinator
111 East 210th Street, Bronx, NY 10467
Phone: 718-405-8545
Email: pbhagat@montefiore.org

FLT3 Mutated Acute Myeloid Leukemia

People with acute myeloid leukemia are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female between the ages of 18 and 60
  • Have a confirmed diagnosis of acute myeloid leukemia

You may not participate in this study if you:

  • Have had prior treatment of acute myeloid leukemia, except hydroxyurea or leukapheresis
  • Have severe liver disease
  • Have active infection such as hepatitis B or hepatitis C
  • Are pregnant or breastfeeding

Contact Information
Ambar Baez, Study Coordinator
111 East 210th Street
Bronx, New York 10467
Phone: 718-920-2006
Email: abaez@montefiore.org

Patients with advanced myeloid malignancies

People with myeloid leukemia are asked to participate in a research study being conducted by Albert Einstein College of Medicine.

You may be eligible to participate in this study if you:

  • Are a male or female 18 years of age or older
  • Have a diagnosis of myeloid leukemia
  • Have adequate blood clotting within the last 7 days

You may not participate in this study if you:

  • Have a history of cardiac disease
  • Have known human immunodeficiency virus (HIV)
  • Have Hepatitis B or Hepatitis C not controlled by therapy
  • Are unable to swallow oral medication
  • Are pregnant, breastfeeding or plan to become pregnant
Contact Information

Kailashben Thummar, Study Coordinator
111 E. 210th Street
Bronx, New York 10467
Phone: (718) 920-6642
Email: kthummar@montefiore.org

IRB #18-06-93-01

Chronic Phase Chronic Myeloid Leukemia

People with Myeloid Leukemia are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a least 18 years of age or older at time of diagnosis
  • Have a diagnosis of Chronic Phase-Chronic Myeloid Leukemia

You may not participate in this study if you:

  • Are receiving treatment for any other prior or active non-Chronic Myeloid Leukemia active malignancy
  • Are participating in any other therapeutic clinical trial for Chronic Myeloid Leukemia disease

Contact Information
Ambar Baez, BS, Study Coordinator
111 East 210th Street, Hofheimer Room 101
Bronx, NY 10467
Phone: (718) 920-2006
Email: ambaez@montefiore.org

Chronic Lymphocytic Leukemia (CLL)

People with Chronic Lymphocytic Leukemia are asked to participate in a research study being conducted by Long Island Jewish Medical Center.

You may be eligible to participate in this study if you:

 

  • Are male or female at least 18 years of age
  • Have a confirmed diagnosis of Chronic Lymphocytic Leukemia
  • Are able to swallow and retain oral medication

You may not participate in this study if you:

  • Have had prior treatment with study drug (TGR-1202)
  • Have had prior autologous stem cell transplant within the last 3 months
  • Have evidence of chronic active Hepatitis B, Hepatitis C or known history of HIV
  • Have evidence of ongoing systemic bacterial, fungal or viral infection, except localized fungal infection of skin/nails
  • Are a woman who is pregnant or lactating

Contact Information

Alexis Mark, Study Coordinator

410 Lakeville Road

New Hyde Park, New York 11042

Phone: (718) 470-4743

Email: Amark1@northwell.edu